ASGR1 and hepatocellular carcinoma: Thus, of the total of individuals with CECs negative for ASGR1 expression, the majority were HCC patients with prior LC (65.6%; 21/32), while there was no difference between cancer-free LC (18.8%; 6/32) and HCC without prior LC (5/32; 15.6%).